Erik Berntorp

251 – 260 of 334

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/4aab0d0f-35ce-477e-a4c5-7b3b36687502?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
25
26
27
28
…
34
next »

2004
Mark Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study
Federici, AB ; Mazurier, C ; Berntorp, Erik ^LU ; Lee, CA ; Scharrer, I ; Goudemand, J ; Lethagen, S ; Nitu, I ; Ludwig, G and Hilbert, L , et al. (2004) In Blood 103(6). p.2032-2038
- Contribution to journal › Article
Mark Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
Steen Carlsson, Katarina ^LU ; Höjgård, Sören ^LU ; Lethagen, Stefan ^LU ; Lindgren, Anna ^LU ; Berntorp, Erik ^LU and Lindgren, Björn ^LU (2004) In Haemophilia 10(5). p.527-541
- Contribution to journal › Article
Mark Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
Steen Carlsson, Katarina ^LU ; Höjgård, Sören ^LU ; Lindgren, Anna ^LU ; Lethagen, Stefan ^LU ; Schulman, S. ; Glomstein, A. ; Tengborn, Lilian ^LU ; Berntorp, Erik ^LU and Lindgren, Björn ^LU (2004) In Haemophilia 10(5). p.515-526
- Contribution to journal › Article
Mark Elective orthopedic surgery for hemophilia patients with inhibitors: New opportunities
Rodriguez-Merchan, EC ; Wiedel, JD ; Wallny, T ; Caviglia, H ; Hvid, L ; Berntorp, Erik ^LU ; Rivard, GE ; Goddard, NJ and Querol, F (2004) In Seminars in Hematology 41(Suppl. 1). p.109-116
- Contribution to journal › Article
2003
Mark Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro.
Astermark, Jan ^LU ; Voorberg, J. ; Lenk, H. ; DiMichele, D. ; Shapiro, A. ; Tjönnfjord, G. and Berntorp, Erik ^LU (2003) In Haemophilia 9(5). p.567-572
- Contribution to journal › Article
Mark Monitoring the bioavailability of FEIBA with a thrombin generation assay
Varadi, K ; Negrier, C ; Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Bordet, JC ; Morfini, M ; Linari, S ; Schwarz, HP and Turecek, PL (2003) In Journal of Thrombosis and Haemostasis 1(11). p.2374-2380
- Contribution to journal › Article
Mark Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Björkman, S ; Blanchette, V. S. ; Fischer, K. ; Giangrande, P. L. F. ; Gringeri, A. ; Ljung, Rolf ^LU ; Manco-Johnson, M. J. and Morfini, M. , et al. (2003) In Haemophilia 9(Suppl 1). p.41278-41278
- Contribution to journal › Letter
Mark The pharmacokinetics of clotting factor therapy.
Berntorp, Erik ^LU and Björkman, S (2003) In Haemophilia 9(4). p.353-359
- Contribution to journal › Article
Mark On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
Steen Carlsson, Katarina ^LU ; Höjgård, Sören ^LU ; Glomstein, A. ; Lethagen, Stefan ^LU ; Schulman, S. ; Tengborn, Lilian ^LU ; Lindgren, Anna ^LU ; Berntorp, Erik ^LU and Lindgren, Björn ^LU (2003) In Haemophilia 9(5). p.555-566
- Contribution to journal › Article
Mark Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay
Turecek, PL ; Varadi, K ; Keil, B ; Negrier, C ; Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Bordet, JC ; Morfini, M ; Linari, S and Schwarz, HP (2003) In Pathophysiology of Haemostasis and Thrombosis 33(1). p.16-22
- Contribution to journal › Article

« previous
1
…
25
26
27
28
…
34
next »